Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Asthma”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01476059
What this trial is testing

Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT

Who this might be right for
Asthma
GlaxoSmithKline 472
Testing effectiveness (Phase 2)Looking for participantsNCT07219173
What this trial is testing

Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Who this might be right for
Asthma
Eli Lilly and Company 531
Testing effectiveness (Phase 2)Active Not RecruitingNCT07054034
What this trial is testing

Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects

Who this might be right for
Bronchial Asthma
Shanghai Mabgeek Biotech.Co.Ltd 160
Not applicableUnknownNCT06147453
What this trial is testing

Effect of OPEP on Mucus Plugging and Airflow Obstruction in Patients with Moderate-to-severe Asthma

Who this might be right for
Asthma
St. Joseph's Healthcare Hamilton 30
Testing effectiveness (Phase 2)Ended earlyNCT06376045
What this trial is testing

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

Who this might be right for
Asthma
Amgen 317
Testing effectiveness (Phase 2)Study completedNCT00818454
What this trial is testing

4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 226
Post-approval studies (Phase 4)Active Not RecruitingNCT05097287
What this trial is testing

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

Who this might be right for
Asthma
Sanofi 1,339
Large-scale testing (Phase 3)Study completedNCT00482508
What this trial is testing

Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients

Who this might be right for
Asthma
Novartis 95
Testing effectiveness (Phase 2)Study completedNCT03387852
What this trial is testing

Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants

Who this might be right for
Asthma
Sanofi 296
Large-scale testing (Phase 3)Study completedNCT00394121
What this trial is testing

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma

Who this might be right for
Asthma
SkyePharma AG 400
Early research (Phase 1)Study completedNCT00386178
What this trial is testing

Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma

Who this might be right for
Asthma
University of North Carolina, Chapel Hill 16
Large-scale testing (Phase 3)Study completedNCT01099722
What this trial is testing

Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma

Who this might be right for
Asthma
Mundipharma Research Limited 261
Large-scale testing (Phase 3)Study completedNCT00649025
What this trial is testing

A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults

Who this might be right for
Asthma
SkyePharma AG 438
Not applicableStudy completedNCT02913092
What this trial is testing

Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients

Who this might be right for
Asthma
Montefiore Medical Center 81
Not applicableUnknownNCT06348407
What this trial is testing

A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE)

Who this might be right for
Moderate to Severe Allergic Asthma
The First Affiliated Hospital with Nanjing Medical University 300
Large-scale testing (Phase 3)UnknownNCT04465175
What this trial is testing

Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics

Who this might be right for
Asthma in Children
Oman Medical Speciality Board 90
Not applicableStudy completedNCT07787507
What this trial is testing

Withania Somnifera for Moderate-to-Severe Persistent Asthma

Who this might be right for
Asthma
Aligarh Muslim University 120
Early research (Phase 1)Ended earlyNCT05035862
What this trial is testing

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

Who this might be right for
Asthma
Emory University 1
Testing effectiveness (Phase 2)Study completedNCT00411567
What this trial is testing

Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

Who this might be right for
Bronchial Asthma
Novartis 26
Not applicableNot Yet RecruitingNCT07421115
What this trial is testing

Multicomponent Breathlessness and Physical Activity Intervention in People With Asthma Using a Digital Platform

Who this might be right for
Asthma (Diagnosis)Breathlessness
University of Newcastle, Australia 300
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation